Q Fever, Acute vs Chronic, Diagnosis, Treatment

A man who works on a sheep farm develops a sudden high fever, severe headache, and muscle aches. It feels like a bad flu, but it does not settle. Blood tests show his liver enzymes are raised, which is not what you expect from ordinary flu. There is no obvious animal bite and no rash.

The clue is his job and the timing: lambing season has just finished, when the birth fluids of infected animals release huge numbers of a hardy organism into the air and dust. He did not need to touch a sick animal; breathing the contaminated air was enough, because it takes only a handful of these organisms to cause infection. This is Q fever, caused by Coxiella burnetii.

Introduction

Q fever is a zoonotic disease found worldwide, caused by the intracellular bacterium Coxiella burnetii. It has two clinical faces: an acute illness (usually a flu-like fever, sometimes with pneumonia or hepatitis) and a chronic illness (most importantly endocarditis) that can appear months to years later.

One idea organizes the whole topic: C. burnetii has a tough, spore-like form that lets it survive in the environment and infect at an extremely low dose, and it lives inside host cells in an acidic compartment that most bacteria could not tolerate. Almost every distinctive feature, its spread by dust and aerosol, its bioterrorism potential, its two-phase serology, and its need for prolonged treatment, follows from this biology.

The name "Q fever" comes from "query fever," the name given before the cause was known.

General properties of Coxiella burnetii

Gram-negative, pleomorphic coccobacillus (though it stains poorly with the routine Gram stain and is better shown with Gimenez staining).

• Obligate intracellular pathogen: it can only grow inside host cells. It was once grouped with the rickettsiae, but molecular studies place it separately (it is more closely related to Legionella).
• Survives and multiplies inside an acidic compartment (a phagolysosome-like vacuole) within the host cell. Most bacteria are killed in this acidic environment; C. burnetii actually needs the acid to become active. This is a key point of difference from many other intracellular pathogens, which avoid the acidic compartment.

The spore-like form: why Coxiella is so hardy

C. burnetii exists in two forms during its life cycle, and this explains its most famous properties.

• The small-cell variant (SCV) is a small, dense, metabolically inactive form. It is spore-like: highly resistant to heat, drying, pressure, and disinfectants, and able to survive for long periods in soil, dust, and animal products outside a host.
• The large-cell variant (LCV) is the larger, metabolically active form that grows and multiplies inside host cells.

The SCV is the reason C. burnetii can spread through contaminated dust and aerosols and survive in the environment for months or years. It is also the reason the infectious dose is extraordinarily low: inhaling as few as one to a handful of organisms can cause disease. That combination, environmental toughness plus a tiny infectious dose plus airborne spread, is exactly why C. burnetii is classified as a potential bioterrorism agent (CDC Category B).

Mode of transmission

Cattle, sheep, and goats are the main reservoirs of C. burnetii, though many other animals can be infected. Infected animals shed the organism in very high numbers in birth products (placenta and birth fluids), and also in milk, urine, and feces. The organism concentrates enormously in the placenta, which is why lambing and kidding seasons are high-risk.

The main route of human infection is inhalation of contaminated aerosols and dust, which is why the disease is linked to farming, veterinary work, and abattoirs, and can affect people who never directly touch an animal. Drinking unpasteurized (raw) milk can also transmit infection. Person-to-person spread is rare. The low infectious dose and airborne route, explained by the spore-like SCV above, are what make even brief environmental exposure enough to cause disease.

How Coxiella burnetii causes disease

After inhalation, C. burnetii is taken up by macrophages. Inside the macrophage it does something unusual: instead of avoiding the acidic phagolysosome, it survives inside it and uses the acidic environment as a signal to switch on its metabolism and multiply. It uses a specialized secretion system to inject proteins that remodel this compartment into a large protective vacuole where it replicates.

Because it hides and multiplies inside host cells, clearing the infection depends on cell-mediated immunity, and antibodies alone cannot reach it. This intracellular lifestyle also explains why treatment needs antibiotics that penetrate cells and act inside the acidic vacuole, and why chronic infection is so hard to cure.

Clinical manifestations of Q fever

Q fever has two very different forms. Most infections are actually without symptoms; when disease does occur, it is either acute or chronic.

Acute Q fever

Acute Q fever usually appears about 2 to 3 weeks after exposure as a self-limiting, flu-like illness: sudden high fever, severe headache, muscle aches, and fatigue. Two features are characteristic and were seen in the hook:

• Hepatitis: raised liver enzymes and sometimes a granulomatous hepatitis are common.
• Atypical pneumonia: C. burnetii is one of the causes of atypical pneumonia, with a dry cough and patchy chest x-ray changes.

Notably, Q fever usually causes no rash, which helps separate it from many rickettsial infections. Most acute cases recover, with or without antibiotics.

Chronic Q fever

Chronic Q fever develops in a minority of patients, sometimes months to years after the initial infection, and is much more serious.

• Endocarditis is the most important form. It classically affects people with pre-existing heart valve disease, prosthetic valves, or weakened immunity. It is a "culture-negative" endocarditis: the valve is infected but routine blood cultures stay negative, so Q fever must be actively suspected and tested for.
• Chronic infection can also cause infection of blood vessels (for example, infected aneurysms) and, in pregnancy, can cause complications.

The acute-versus-chronic distinction drives everything else, the serology used to diagnose it and the length and type of treatment.

Laboratory diagnosis of Q Fever

Sample: whole blood (for PCR early in illness) and serum (for serological testing).

Culture: isolating C. burnetii is possible but is not done routinely, because the organism is highly infectious and dangerous to laboratory staff. For this reason it must only be handled in high-containment laboratories, which fits its status as a CDC Category B bioterrorism agent. Diagnosis in practice relies on PCR and serology, not culture.

Polymerase chain reaction (PCR) assay

During the acute phase of illness, a sample of whole blood can be tested by polymerase chain reaction (PCR) assay to determine if a patient has Q fever.  This method is most sensitive in the first week of illness but sensitivity decreases rapidly following the administration of appropriate antibiotics.

Although a positive PCR result is helpful, a negative result does not rule out the diagnosis.

Serology is the mainstay of diagnosis, and the key to reading it is the two-phase antigen system, which cleverly separates acute from chronic disease.

Serological studies

• Antibodies to C. burnetii, with detectable antibody titers usually observed by 7 to 10 days after the onset of illness.
• There are two distinct antigenic phases to which humans develop antibody responses.
  • Acute Q fever: the antibody response to Phase II antigen dominates, and Phase II titers are higher than Phase I. So high Phase II antibody points to acute disease.
  • Chronic Q fever: the pattern reverses. A high and rising Phase I IgG titer (by current U.S. case definitions, ≥1:800) that exceeds the Phase II titer points to chronic disease, such as endocarditis. So a high Phase I titer is the warning sign for chronic Q fever.

Serological tests such as microagglutination, complement fixation, immunofluorescence and enzyme linked immunosorbent assay using phase I and phase II antigens are commonly performed.

The gold standard serologic test for diagnosis of acute Q fever is the indirect immunofluorescence assay (IFA) using C. burnetii antigen, performed on paired serum samples to demonstrate a significant (four-fold) rise in antibody titers. The first sample should be taken as early in the disease as possible, preferably in the first week of symptoms, and the second sample should be taken 2 to 4 weeks later.

Paired samples taken 2-3 weeks apart demonstrating a significant (four-fold) rise in antibody titer provides the best evidence for a correct diagnosis of acute Q fever.

Treatment of Q fever

Treatment depends on whether the disease is acute or chronic, and both follow from the intracellular biology.

Acute Q fever. The drug of choice is doxycycline. It is most effective when started early, within the first few days of illness. Many mild acute cases are self-limiting, but treatment shortens the illness and, importantly, reduces the risk of progression to chronic disease.

Chronic Q fever (endocarditis). This is much harder to cure, because the organism lives inside an acidic compartment in host cells. The standard treatment is a prolonged combination of doxycycline plus hydroxychloroquine. The reason for adding hydroxychloroquine is elegant and worth remembering: it raises the pH of the acidic vacuole, which makes doxycycline work far better inside that compartment. This combination must be given for a long time, often 18 months or more, with monitoring of antibody titers to judge response.

Beta-lactams are not used, because C. burnetii is intracellular and beta-lactams cannot reach or act on it, the same principle seen across the atypical-pneumonia and intracellular organisms.

Prevention of Q fever

Prevention centers on the animal source and the environment: safe handling and disposal of birth products from livestock, pasteurizing milk, and protecting high-risk workers (farmers, vets, abattoir staff). A Q fever vaccine exists and is used in some countries for high-risk occupational groups, but it is not available everywhere.

Because it is a cause of atypical pneumonia, C. burnetii is compared with the other atypical-pneumonia organisms in the table on the Legionella pneumophila article.

How to Remember

Key exam facts in one table

Where Students Get Confused

References

1. Tille, P. M. (2022). Bailey & Scott's Diagnostic Microbiology (15th ed.). Elsevier.
2. Carroll, K. C., Pfaller, M. A., et al. (2020). Murray's Medical Microbiology (9th ed.). Elsevier.
3. Maurin, M., & Raoult, D. (1999). Q fever. Clinical Microbiology Reviews, 12(4), 518–553.
4. Anderson, A., Bijlmer, H., Fournier, P. E., et al. (2013). Diagnosis and management of Q fever, United States, 2013: recommendations from CDC and the Q Fever Working Group. MMWR Recommendations and Reports, 62(RR-03), 1–30.
5. Centers for Disease Control and Prevention. Q fever: information for healthcare providers. CDC (current version).